These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22548259)

  • 21. Systemic sclerosis sine scleroderma: a case report of anterior uveitis.
    Borges T; Vilaça J; Ferreira S; Chora I; Silva S; Dias C
    Reumatismo; 2015 Jun; 67(1):21-5. PubMed ID: 26150271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.
    Terras S; Hartenstein H; Höxtermann S; Gambichler T; Kreuter A
    Int J Dermatol; 2016 Aug; 55(8):882-5. PubMed ID: 26499848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the measurement of anti-PM-1α antibodies at least as important as that of other systemic sclerosis-specific antibodies? Comment on the article by D'Aoust et al.
    Muro Y; Sugiura K; Akiyama M
    Arthritis Rheumatol; 2014 Nov; 66(11):3248. PubMed ID: 25077816
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.
    Heijnen IA; Foocharoen C; Bannert B; Carreira PE; Caporali R; Smith V; Kumánovics G; Becker MO; Vanthuyne M; Simsek I; Bocelli-Tyndall C; Walker UA
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):96-102. PubMed ID: 23101460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of 405 Japanese patients with systemic sclerosis.
    Hashimoto A; Endo H; Kondo H; Hirohata S
    Mod Rheumatol; 2012 Apr; 22(2):272-9. PubMed ID: 21874591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of serum anti-annexin V antibodies in Egyptian patients with scleroderma.
    El Serougy IM; Shahin AA; Soliman DA; Akhnoukh AF; Mousa SM
    Egypt J Immunol; 2009; 16(1):1-8. PubMed ID: 20726317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: Association with extent of skin sclerosis.
    Yanaba K; Hayashi M; Yoshihara Y; Nakagawa H
    J Dermatol; 2016 Aug; 43(8):954-7. PubMed ID: 26945563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study of antithyroid antibodies by the antiglobulin binding method in several diseases of the thyroid gland].
    Sidorov KA; Dygin VP
    Ter Arkh; 1967 Feb; 39(2):37-43. PubMed ID: 4888241
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
    Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
    Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
    Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis.
    Ugor E; Simon D; Almanzar G; Pap R; Najbauer J; Németh P; Balogh P; Prelog M; Czirják L; Berki T
    Clin Immunol; 2017 Nov; 184():54-62. PubMed ID: 28522286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
    Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
    J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu.
    Bosello S; Basile U; De Lorenzis E; Gulli F; Canestrari G; Napodano C; Parisi F; Pocino K; Di Mario C; Tolusso B; Ferraccioli G; Gremese E
    J Clin Pathol; 2018 Jul; 71(7):620-625. PubMed ID: 29447111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic activity of anti-thyrotropin anti-idiotypic antibody.
    Farid NR; Brioñes-Urbina R; Nazrul-Islam M
    J Cell Biochem; 1982; 19(4):305-13. PubMed ID: 6298253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis.
    Carmona FD; Serrano A; Rodríguez-Rodríguez L; Callejas JL; Simeón CP; Carreira P; Castañeda S; Solans R; Blanco R; ; ; González-Gay MA; Martín J
    J Rheumatol; 2012 Jun; 39(6):1275-9. PubMed ID: 22589256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scleroderma Induced by Pembrolizumab: A Case Series.
    Barbosa NS; Wetter DA; Wieland CN; Shenoy NK; Markovic SN; Thanarajasingam U
    Mayo Clin Proc; 2017 Jul; 92(7):1158-1163. PubMed ID: 28599746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Scleroderma].
    Bardet F
    Krankenpfl Soins Infirm; 2007; 100(7):55. PubMed ID: 17760381
    [No Abstract]   [Full Text] [Related]  

  • 40. Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.
    Gelber AC; Pillemer SR; Baum BJ; Wigley FM; Hummers LK; Morris S; Rosen A; Casciola-Rosen L
    Ann Rheum Dis; 2006 Aug; 65(8):1028-32. PubMed ID: 16414973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.